Cholesterol-lowering drug linked to sleep disruptions

“The findings are significant because sleep problems can affect quality of life and may have adverse health consequences, such as promoting weight gain and insulin resistance,” said Beatrice Golomb, M.D., lead author of the study and an associate professor of medicine and family and preventive medicine at the University of California at San Diego School of Medicine.

In the largest study of its kind, researchers compared two types of cholesterol-lowering drugs called statins — simvastatin, which is lipophilic (soluble in fats), and pravastatin, which is hydrophilic (soluble in water).

Because simvastatin is fat soluble it can more readily penetrate cell membranes and cross the blood brain barrier into the brain. The brain controls sleep, and many of the brain’s nerve cells are wrapped in a fatty insulating sheath called myelin.

“The results showed that simvastain use was associated with significantly worse sleep quality. A significantly greater number of individuals taking simvastatin reported sleep problems than those taking either pravastain or the placebo,” Golomb said. “On average, the lipophilic statin had a greater adverse effect on sleep quality.”

In past studies and case reports, some people on statins reported having insomnia or nightmares.

“Several small studies were done early on, including those focused on lipophilic versus hydrophilic statins,” Golomb said. “Most (researchers) didn’t see a difference in sleep, but they had short durations of follow-up and enrolled just a handful of people — often fewer than 20, which was not enough to see a difference unless it was very large.

“One of these studies did report a significant difference between pravastatin and simvastatin. But without more and bigger studies, an effect was not considered to be established.”

In this study, researchers tested 1,016 healthy adult men and women for six months in a randomized, double-blind, placebo-controlled trial using simvastatin, given at 20 milligrams (mg), pravastatin at 40 mg, or a placebo. They assessed outcomes with the Leeds sleep scale, a visual analog scale of sleep quality, and a rating scale of sleep problems. Both scales were measured before and during treatment.

“Those who reported developing much worse sleep on study medication also showed a significant adverse change in aggression scores compared to others,” Golomb said “We should also point out that although the average effect on sleep was detrimental on simvastatin, this does not mean that everyone on simvastatin will experience worse sleep.”

Researchers did not include patients with heart disease or diabetes due to concerns about assigning these people to placebos.

“Patients taking simvastatin who are having sleep problems should consult with their doctor,” Golomb said. “Sleep deprivation is a major problem in a minor number of people.”

Source: American Heart Association

Using a fan during sleep lowers SIDS risk by 72 percent
Infants who slept in a bedroom with a fan ventilating the air had a 72 percent lower risk of Sudden Infant Death Syndrome compared to infants who slept in a bedroom without a fan, according to a new study by the Kaiser Permanente Division of Research. The study appears in the October issue of the Archives of Pediatric & Adolescent Medicine.
Strippers, armadillos inspire Ig Nobel winners
(AP) -- Deborah Anderson had heard the urban legends about the contraceptive effectiveness of Coca-Cola products for years. So she and her colleagues decided to put the soft drink to the test. In the lab, that is.
Learning to shape your brain activity
A study in the Oct. 1 issue of the journal Sleep shows that the successful manipulation of sensorimotor rhythm (SMR) amplitude by instrumental SMR conditioning (ISC) improved sleep quality as well as declarative learning. ISC might thus be considered a promising non-pharmacological treatment for primary insomnia.
Direct recording shows brain signal persists even in dreamless sleep
Neuroscientists at Washington University School of Medicine in St. Louis have taken one of the first direct looks at one of the human brain's most fundamental "foundations": a brain signal that never switches off and may support many cognitive functions.
Restless nights put older adults at risk for depression recurrence
Nearly 60 percent of the nation's elderly have trouble sleeping, whether it's a lot of tossing and turning or outright bouts of insomnia. While for most people sleeplessness can be annoying at best or unhealthy at worst, for elderly individuals who have suffered from depression in the past, poor sleep may be the first sign that a new bout of depression is coming on.
Scientists discover why a mother's high-fat diet contributes to obesity in her children
New research published online in The FASEB Journal suggests that pregnant women should think twice about high-fat foods. In a study from the University of Cincinnati and the Medical College of Georgia, scientists found that female mice fed high fat diets were more likely to have oversized offspring (a risk factor for overweight and obesity) because fat causes the placenta to go into "overdrive" by providing too many nutrients to the fetus. This information also suggests that the reverse may be true as well—high fat diets may help prevent undersized babies.
TB Bacterium Uses Its Sugar Coat To Sweeten Its Chances Of Living In Lungs
(PhysOrg.com) -- Common strains of tuberculosis-causing bacteria have hijacked the human body’s immune response to play tricks on cells in the lungs, scientists say.
Scientists pinpoint genetic driver of narcolepsy
Scientists in Japan have identified a genetic mutation linked to narcolepsy, a disease that can cause someone to doze off in mid-sentence or behind the wheel of a car, a study released Sunday reports.

Cholesterol-lowering drug linked to sleep disruptions

Related stories:

News discussion: